Pendal Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,160
Closed -$213K 506
2022
Q3
$213K Buy
+1,160
New +$231K ﹤0.01% 437
2022
Q2
Sell
-5,301
Closed -$1.33M 480
2022
Q1
$1.33M Buy
5,301
+986
+23% +$248K 0.01% 312
2021
Q4
$1.11M Buy
+4,315
New +$1.06M 0.01% 322
2021
Q3
Sell
-2,951
Closed -$610K 608
2021
Q2
$610K Buy
2,951
+793
+37% +$162K 0.01% 394
2021
Q1
$406K Buy
+2,158
New +$381K ﹤0.01% 427
2020
Q2
Sell
-14,291
Closed -$1.28M 469
2020
Q1
$1.28M Sell
14,291
-14,185
-50% -$1.84M 0.02% 198
2019
Q4
$4.21M Buy
28,476
+5,077
+22% +$682K 0.06% 145
2019
Q3
$2.82M Sell
23,399
-26,785
-53% -$3.46M 0.04% 173
2019
Q2
$6.78M Sell
50,184
-22,815
-31% -$2.88M 0.09% 109
2019
Q1
$9.52M Hold
72,999
0.13% 89
2018
Q4
$9.08M Buy
72,999
+39,078
+115% +$5.25M 0.14% 93
2018
Q3
$4.72M Buy
+33,921
New +$4.22M 0.06% 141
2017
Q4
Sell
-24,103
Closed -$1.92M 474
2017
Q3
$1.92M Sell
24,103
-10,786
-31% -$867K 0.03% 224
2017
Q2
$3.04M Buy
+34,889
New +$2.95M 0.04% 201

Other funds holding HCA

Pendal Group's HCA Position: Q4 2022 in Review

Pendal Group sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 1,160 shares — an estimated $213K sold.

Pendal Group first reported a position in HCA in Q2 2017 and held it in 14 quarters. The position peaked at $9.52M in Q1 2019. 961 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • Pendal Group reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
  • Pendal Group sold 1,160 HCA Healthcare shares in Q4 2022, an estimated $213K.
  • Pendal Group first reported a position in HCA Healthcare in Q2 2017 and held it in 14 quarters.
  • Pendal Group's HCA Healthcare position peaked at $9.52M in Q1 2019.
  • 961 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.